科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/22 | 5,000 | 5,100 | 5,000 | 5,050 | +40 | +0.8% | 141,300 |
2020/07/21 | 4,940 | 5,030 | 4,930 | 5,010 | -30 | -0.6% | 234,900 |
2020/07/20 | 5,060 | 5,110 | 5,030 | 5,040 | -20 | -0.4% | 119,700 |
2020/07/17 | 5,000 | 5,120 | 4,995 | 5,060 | +10 | +0.2% | 115,100 |
2020/07/16 | 5,090 | 5,100 | 5,030 | 5,050 | -140 | -2.7% | 183,800 |
2020/07/15 | 5,160 | 5,230 | 5,120 | 5,190 | +30 | +0.6% | 151,900 |
2020/07/14 | 5,180 | 5,260 | 5,140 | 5,160 | -80 | -1.5% | 130,900 |
2020/07/13 | 5,130 | 5,260 | 5,120 | 5,240 | +120 | +2.3% | 117,400 |
2020/07/10 | 5,170 | 5,210 | 5,120 | 5,120 | -10 | -0.2% | 113,500 |
2020/07/09 | 5,200 | 5,210 | 5,080 | 5,130 | -70 | -1.3% | 164,200 |
2020/07/08 | 5,330 | 5,390 | 5,200 | 5,200 | -120 | -2.3% | 166,400 |
2020/07/07 | 5,310 | 5,360 | 5,170 | 5,320 | -10 | -0.2% | 186,200 |
2020/07/06 | 5,270 | 5,380 | 5,270 | 5,330 | +90 | +1.7% | 96,400 |
2020/07/03 | 5,220 | 5,270 | 5,170 | 5,240 | +10 | +0.2% | 98,300 |
2020/07/02 | 5,240 | 5,290 | 5,180 | 5,230 | -60 | -1.1% | 226,000 |
2020/07/01 | 5,500 | 5,540 | 5,280 | 5,290 | -220 | -4% | 167,800 |
2020/06/30 | 5,550 | 5,600 | 5,510 | 5,510 | -20 | -0.4% | 150,600 |
2020/06/29 | 5,540 | 5,580 | 5,500 | 5,530 | -60 | -1.1% | 163,900 |
2020/06/26 | 5,520 | 5,610 | 5,520 | 5,590 | +70 | +1.3% | 96,100 |
2020/06/25 | 5,480 | 5,550 | 5,450 | 5,520 | -30 | -0.5% | 184,900 |
2020/06/24 | 5,610 | 5,660 | 5,510 | 5,550 | -160 | -2.8% | 232,600 |
2020/06/23 | 5,680 | 5,720 | 5,590 | 5,710 | +40 | +0.7% | 104,500 |
2020/06/22 | 5,650 | 5,720 | 5,640 | 5,670 | +20 | +0.4% | 84,500 |
2020/06/19 | 5,660 | 5,680 | 5,570 | 5,650 | -10 | -0.2% | 146,800 |
2020/06/18 | 5,630 | 5,690 | 5,600 | 5,660 | +70 | +1.3% | 103,200 |
2020/06/17 | 5,630 | 5,650 | 5,570 | 5,590 | -40 | -0.7% | 156,700 |
2020/06/16 | 5,650 | 5,670 | 5,570 | 5,630 | +140 | +2.6% | 197,700 |
2020/06/15 | 5,520 | 5,640 | 5,490 | 5,490 | -80 | -1.4% | 188,900 |
2020/06/12 | 5,550 | 5,580 | 5,470 | 5,570 | -40 | -0.7% | 264,100 |
2020/06/11 | 5,700 | 5,700 | 5,590 | 5,610 | -120 | -2.1% | 150,500 |
2020/06/10 | 5,680 | 5,740 | 5,640 | 5,730 | +70 | +1.2% | 213,800 |
2020/06/09 | 5,710 | 5,730 | 5,610 | 5,660 | -110 | -1.9% | 180,100 |
2020/06/08 | 5,770 | 5,780 | 5,720 | 5,770 | -70 | -1.2% | 180,800 |
2020/06/05 | 5,810 | 5,860 | 5,760 | 5,840 | -40 | -0.7% | 202,100 |
2020/06/04 | 5,860 | 5,990 | 5,810 | 5,880 | +70 | +1.2% | 277,900 |
2020/06/03 | 5,850 | 5,890 | 5,790 | 5,810 | +30 | +0.5% | 191,000 |
2020/06/02 | 5,780 | 5,790 | 5,730 | 5,780 | -40 | -0.7% | 181,200 |
2020/06/01 | 5,900 | 5,920 | 5,800 | 5,820 | -100 | -1.7% | 133,800 |
2020/05/29 | 5,800 | 5,950 | 5,780 | 5,920 | +160 | +2.8% | 316,900 |
2020/05/28 | 5,900 | 5,920 | 5,710 | 5,760 | -150 | -2.5% | 228,900 |
2020/05/27 | 5,730 | 5,950 | 5,730 | 5,910 | +60 | +1% | 206,500 |
2020/05/26 | 5,810 | 5,870 | 5,770 | 5,850 | +70 | +1.2% | 151,500 |
2020/05/25 | 5,700 | 5,800 | 5,650 | 5,780 | +40 | +0.7% | 181,500 |
2020/05/22 | 5,780 | 5,860 | 5,690 | 5,740 | -60 | -1% | 263,100 |
2020/05/21 | 5,670 | 5,840 | 5,670 | 5,800 | +90 | +1.6% | 153,100 |
2020/05/20 | 5,650 | 5,740 | 5,610 | 5,710 | +70 | +1.2% | 113,000 |
2020/05/19 | 5,720 | 5,730 | 5,570 | 5,640 | -20 | -0.4% | 178,600 |
2020/05/18 | 5,600 | 5,710 | 5,590 | 5,660 | +70 | +1.3% | 152,700 |
2020/05/15 | 5,600 | 5,640 | 5,510 | 5,590 | -30 | -0.5% | 160,500 |
2020/05/14 | 5,740 | 5,740 | 5,600 | 5,620 | -130 | -2.3% | 184,900 |
1201~
1250
件表示中 / 3724件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 382,500円 | -6.4% | -71.8% | 4.97% | 42.72倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 372,500円 | +21.7% | +999.9% | 0.00% | 15.60倍 | 5.16倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,600円 | +7.9% | -3.3% | 2.71% | 8.22倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 202,200円 | +3.1% | -6.5% | 2.37% | 9.38倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム